Founded in February 2022, Innosus is a medical-device startup focused on the aesthetic market. Its flagship product, Alltite, repurposes dielectric-heating principles from cancer treatment to target the mid- and deep-dermis layers while minimizing epidermal temperature, enabling procedures that can be performed without anesthesia. The device’s DLTD (Dermis Layer Targeted Dielectric heating) system, now under international patent review, delivers simultaneous dermal and SMAS stimulation, combining radio-frequency tightening with HIFU-like lifting effects. By reducing heat concentration in subcutaneous fat, Alltite also aims to lessen common side effects such as cheek laxity. Management plans to channel new capital into expanding across North American, European and Asian markets and into further R&D for next-generation products. The company recently secured ₩14.2 billion in Series A funding to support these initiatives.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2026